Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-05-29 11:55 am Purchase |
2024-05-21 | 13G | Erasca, Inc. ERAS |
Frazier Life Sciences Public Fund, L.P. | 16,216,216 5.900% |
16,216,216 (New Position) |
Filing History |
| 2024-05-06 12:59 pm Purchase |
2024-04-29 | 13G | AnaptysBio, Inc. ANAB |
Frazier Life Sciences Public Fund, L.P. | 1,917,191 7.000% |
1,917,191 (New Position) |
Filing History |
| 2024-04-10 4:44 pm Purchase |
2024-04-03 | 13G | AN2 Therapeutics, Inc. ANTX |
Frazier Life Sciences Public Fund, L.P. | 1,488,889 5.000% |
1,488,889 (New Position) |
Filing |
| 2024-04-09 4:26 pm Purchase |
2024-04-02 | 13G | Elevation Oncology, Inc. ELEV |
Frazier Life Sciences Public Fund, L.P. | 2,958,579 6.100% |
2,958,579 (New Position) |
Filing History |
| 2024-03-29 10:40 am Purchase |
2024-03-25 | 13G | Puma Biotechnology, Inc. PBYI |
Frazier Life Sciences Public Fund, L.P. | 2,631,713 5.400% |
2,631,713 (New Position) |
Filing History |
| 2024-02-22 1:22 pm Purchase |
2024-02-20 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 3,687,867 8.900% |
105,573 (+2.95%) |
Filing History |
| 2024-02-13 12:44 pm Sale |
2023-12-31 | 13G | GRITSTONE BIO INC GRTSQ |
Frazier Life Sciences Public Fund, L.P. | 1,092,185 1.100% |
-4,131,470 (-79.09%) |
Filing History |
| 2024-02-13 12:36 pm Sale |
2023-12-31 | 13G | Theseus Pharmaceuticals, Inc. THRX |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-2,248,194 (Position Closed) |
Filing History |
| 2024-02-09 11:41 am Purchase |
2024-02-08 | 13G | Adverum Biotechnologies, Inc. ADVM |
Frazier Life Sciences Public Fund, L.P. | 1,041,667 11.000% |
1,041,667 (New Position) |
Filing History |
| 2024-01-25 1:24 pm Purchase |
2024-01-23 | 13G | ORIC Pharmaceuticals, Inc. ORIC |
Frazier Life Sciences Public Fund, L.P. | 4,142,855 6.200% |
4,142,855 (New Position) |
Filing History |
| 2023-12-14 1:33 pm Purchase |
2023-12-12 | 13D | KalVista Pharmaceuticals, Inc. KALV |
Frazier Life Sciences Public Fund, L.P. | 3,582,294 10.400% |
343,435 (+10.60%) |
Filing History |
| 2023-10-05 12:23 pm Sale |
2023-10-03 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 0 0.000% |
-3,708,838 (Position Closed) |
Filing History |
| 2023-09-27 10:26 am Purchase |
2023-09-25 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,806,472 20.200% |
25,000 (+0.26%) |
Filing History |
| 2023-05-26 5:29 pm Purchase |
2023-05-24 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 10,125,788 18.500% |
1,697,683 (+20.14%) |
Filing History |
| 2023-05-05 4:13 pm Purchase |
2023-04-13 | 13D | Phathom Pharmaceuticals, Inc. PHAT |
Frazier Life Sciences Public Fund, L.P. | 8,428,105 19.300% |
8,428,105 (New Position) |
Filing History |
| 2023-05-05 4:12 pm Purchase |
2023-04-28 | 13D | HilleVax, Inc. HLVX |
Frazier Life Sciences Public Fund, L.P. | 9,781,472 25.000% |
144,240 (+1.50%) |
Filing History |
| 2023-04-17 5:29 pm Sale |
2023-04-13 | 13G | Allakos Inc. ALLK |
Frazier Life Sciences Public Fund, L.P. | 392,269 0.500% |
-4,399,731 (-91.81%) |
Filing History |
| 2023-02-14 12:19 pm Sale |
2022-12-31 | 13G | Cogent Biosciences, Inc. COGT |
Frazier Life Sciences Public Fund, L.P. | 2,109,154 3.000% |
-78,850 (-3.60%) |
Filing History |
| 2023-02-14 12:19 pm Sale |
2022-12-31 | 13G | TRICIDA INC TCDAQ |
Frazier Life Sciences Public Fund, L.P. | 1,500,000 2.500% |
-2,082,093 (-58.13%) |
Filing History |
| 2023-02-14 12:12 pm Purchase |
2022-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Frazier Life Sciences Public Fund, L.P. | 3,708,838 5.400% |
936,776 (+33.79%) |
Filing History |